Interscalene Block Versus Anterior Suprascapular Block for Post-Thoracotomy Shoulder Pain
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Interscalene block, Anterior suprascapular block, Epidural analgesia.
- Who it may be relevant to
- Registry conditions: Interscalene Block, Anterior Suprascapular Block, Thoracotomy, Shoulder Pain. Basic parameters: 18 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Interscalene Block Versus Anterior Suprascapular Block for Post-Thoracotomy Shoulder Pain: A Randomized Controlled Trial
Overview
This study aims to compare the frequency of occurrence of ipsilateral shoulder pain in patients undergoing thoracotomy with ultrasound-guided interscalene block, anterior suprascapular block as adjunct to epidural and epidural block only.
Detailed description
Thoracotomy is one type of surgery associated with challenging pain that needs to be promptly addressed to avoid post-operative respiratory complications and aid in effective postoperative physiotherapy and patient recovery. Epidural analgesia is considered the gold standard for the thoracotomy procedure. Ipsilateral shoulder pain (ISP) following thoracotomy has an incidence ranging from 37% to 85%.
Being so common, this pain needs more attention and proper anticipation, and management. ISP is usually non-responsive to the effects of epidural and paravertebral blocks.
Interventions
- Other Interscalene block
Patients will receive an ultrasound-guided interscalene block. - Other Anterior suprascapular block
Patients will receive an ultrasound-guided anterior suprascapular block. - Other Epidural analgesia
Patients will not receive regional blocks apart from epidural analgesia.
Primary outcome measures
- Frequency of occurrence of ipsilateral shoulder pain [Time frame: 72 hours postoperatively]
Secondary outcome measures (10)
- Degree of pain [Time frame: 72 hours postoperatively]
- Mean arterial pressure [Time frame: 48 hours postoperatively]
- Heart rate [Time frame: 48 hours postoperatively]
- Incidence of complications [Time frame: 72 hours postoperatively]
- Time to first request of rescue analgesia [Time frame: 72 hours postoperatively]
- Total number of rescue analgesia [Time frame: 72 hours postoperatively]
- Peak Expiratory Flow Rate [Time frame: 72 hours postoperatively]
- Forced Expiratory Volume in 1 second (FEV1) [Time frame: 72 hours postoperatively]
- Forced vital capacity (FVC) [Time frame: 72 hours postoperatively]
- Forced Expiratory Volume in 1 second (FEV1) / Forced vital capacity (FVC) ratio [Time frame: 72 hours postoperatively]
Eligibility criteria
Inclusion criteria
- Age > 18 years and ≤ 65 years old.
- American Society of Anesthesiologists (ASA) physical status II-III.
- Body mass index 18-35 kg/m2.
- Patients who have a confirmed diagnosis of lung cancer and are scheduled for elective open-lung surgery.
Exclusion criteria
- Allergy to local anesthetics.
- Known psychiatric or neurologic disorders.
- Alcohol or narcotics abuse.
- Contraindications to thoracic epidural or suprascapular block, or interscalene block, e.g., coagulopathy or local infection.
- Pre-existing shoulder symptoms.
- History of previous thoracotomy.
- Severe restrictive or obstructive pulmonary disease.
- Pre-existing contralateral diaphragmatic paralysis.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Cairo University — Cairo
Identifiers
NCT: NCT07424638 · AP2512-501-152-202